The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire workforce, according to a press release Monday. The move is part of a ...

The genetic testing company 23andMe has said it would slash 40% of its workforce after recording a drop in revenues.

As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.

Me has announced layoffs at the organization. It will also discontinue its therapy programs and clinical trials to refocus ...

Genetics-testing company 23andMe has warned there is “substantial doubt” over its continued survival unless it raises new ...

DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

Though 23andMe says the restructuring plan will cost it around $12 million, it expects to save more than $35 million as a ...

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

As the company restructures, it will pivot to selling genetic tests to consumers and using that data for research. Also: medicinal and tech advancements in cancer care; research monkeys roundup.

In the company’s statement, CEO Anne Wojcicki called Monday’s restructuring “difficult but necessary actions” that will ...

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...

23andMe faced a significant hurdle when seven out of eight board members stepped down in September, expressing discontent ...